| 000 | 01594 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250512060649.0 | ||
| 264 | 0 | _c19870609 | |
| 008 | 198706s 0 0 eng d | ||
| 022 | _a0315-162X | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMizushima, Y | |
| 245 | 0 | 0 |
_aA multicenter double blind controlled study of lipo-PGE1, PGE1 incorporated in lipid microspheres, in peripheral vascular disease secondary to connective tissue disorders. _h[electronic resource] |
| 260 |
_bThe Journal of rheumatology _cFeb 1987 |
||
| 300 |
_a97-101 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAlprostadil _xadverse effects |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aConnective Tissue Diseases _xcomplications |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGangrene _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aLipids |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMicrospheres |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 |
_aRaynaud Disease _xdrug therapy |
| 650 | 0 | 4 |
_aSkin Ulcer _xdrug therapy |
| 650 | 0 | 4 |
_aVascular Diseases _xdrug therapy |
| 700 | 1 | _aShiokawa, Y | |
| 700 | 1 | _aHomma, M | |
| 700 | 1 | _aKashiwazaki, S | |
| 700 | 1 | _aIchikawa, Y | |
| 700 | 1 | _aHashimoto, H | |
| 700 | 1 | _aSakuma, A | |
| 773 | 0 |
_tThe Journal of rheumatology _gvol. 14 _gno. 1 _gp. 97-101 |
|
| 999 |
_c3559311 _d3559311 |
||